HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eileen M Shore Selected Research

Activin Receptors (Activin Receptor)

11/2020Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesis.
9/2010Inherited human diseases of heterotopic bone formation.
1/2010Investigations of activated ACVR1/ALK2, a bone morphogenetic protein type I receptor, that causes fibrodysplasia ossificans progressiva.
3/2009Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1.
5/2008Early diagnosis of fibrodysplasia ossificans progressiva.
3/2008Dysregulated BMP signaling and enhanced osteogenic differentiation of connective tissue progenitor cells from patients with fibrodysplasia ossificans progressiva (FOP).
1/2008When one skeleton is enough: approaches and strategies for the treatment of fibrodysplasia ossificans progressiva (FOP).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eileen M Shore Research Topics

Disease

42Myositis Ossificans (Fibrodysplasia Ossificans Progressiva)
01/2022 - 01/2003
18Heterotopic Ossification (Ectopic Ossification)
01/2019 - 09/2003
16Inborn Genetic Diseases (Disease, Hereditary)
01/2022 - 04/2003
5Inflammation (Inflammations)
01/2016 - 01/2003
3Mucopolysaccharidoses
01/2022 - 11/2015
3Mucopolysaccharidosis I (Hurler Syndrome)
01/2022 - 07/2013
3Pseudohypoparathyroidism
01/2020 - 05/2007
3Progressive Osseous Heteroplasia
01/2018 - 04/2003
2Lysosomal Storage Diseases (Lysosomal Storage Disease)
01/2022 - 12/2014
2Bone Diseases (Bone Disease)
01/2022 - 11/2019
2Type 2 Diabetes Mellitus (MODY)
01/2020 - 01/2018
2Obesity
01/2020 - 01/2018
2Brachydactyly
01/2020 - 07/2017
2Hypogonadism (Hypergonadotropic Hypogonadism)
01/2020 - 01/2018
2Disease Progression
12/2014 - 02/2007
1Diffuse Intrinsic Pontine Glioma
01/2021
1Osteochondrodysplasias (Spondyloepiphyseal Dysplasia)
11/2020
1Hypothyroidism
01/2020
1Hypertension (High Blood Pressure)
01/2018
1Weight Gain
01/2018
1Glucose Intolerance
01/2018
1Congenital Abnormalities (Deformity)
01/2018
1Hallux Valgus
07/2017
1Hypertrophy
11/2015
1Type B1 Brachydactyly
01/2012
1Edema (Dropsy)
12/2011
1Fatigue
12/2011
1Virus Diseases (Viral Diseases)
12/2011
1Soft Tissue Injuries (Soft Tissue Injury)
12/2011
1Neoplasms (Cancer)
02/2008
1Osteochondroma (Osteocartilaginous Exostosis)
02/2008
1Aplastic Anemia (Anemia, Hypoplastic)
02/2007
1Paresis (Hemiparesis)
04/2003

Drug/Important Bio-Agent (IBA)

28Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
01/2022 - 04/2003
13Type I Bone Morphogenetic Protein ReceptorsIBA
11/2020 - 05/2006
7Activin Receptors (Activin Receptor)IBA
11/2020 - 01/2008
6Bone Morphogenetic Protein ReceptorsIBA
01/2021 - 05/2014
5GlycosaminoglycansIBA
01/2022 - 07/2013
5Serine (L-Serine)FDA Link
06/2012 - 09/2007
5Glycine (Aminoacetic Acid)FDA LinkGeneric
06/2012 - 09/2007
4activin AIBA
01/2018 - 02/2008
4Phosphotransferases (Kinase)IBA
07/2017 - 03/2009
4Activins (Activin)IBA
07/2017 - 05/2007
4Proteins (Proteins, Gene)FDA Link
09/2007 - 03/2003
3Iduronidase (alpha-L-Iduronidase)IBA
01/2022 - 07/2013
3GTP-Binding Proteins (G-Protein)IBA
11/2011 - 04/2003
3Adenylyl Cyclases (Adenylyl Cyclase)IBA
11/2011 - 04/2003
2Codon (Codons)IBA
01/2022 - 05/2008
2Parathyroid Hormone (Parathormone)IBA
01/2020 - 01/2018
2Growth Hormone (Somatotropin)IBA
01/2020 - 01/2018
2GlucuronidaseIBA
11/2019 - 11/2015
2PalovaroteneIBA
01/2019 - 01/2016
2DNA (Deoxyribonucleic Acid)IBA
01/2018 - 04/2003
2LigandsIBA
01/2018 - 09/2007
2Messenger RNA (mRNA)IBA
11/2015 - 04/2003
2Bone Morphogenetic Protein 4IBA
04/2007 - 03/2004
2RNA (Ribonucleic Acid)IBA
04/2003 - 03/2003
1EnzymesIBA
01/2022
1LithiumIBA
01/2022
1Dermatan SulfateIBA
01/2022
1dipinacoline glutamateIBA
01/2021
1Chondroitin Sulfates (Chondroitin Sulfate)IBA
11/2019
1Biomarkers (Surrogate Marker)IBA
11/2019
1Oxygen (Dioxygen)IBA
01/2016
1Differentiation AntigensIBA
11/2015
1Simvastatin (Zocor)FDA LinkGeneric
12/2014
1Heparitin Sulfate (Heparan Sulfate)IBA
07/2013
1Amino AcidsFDA Link
01/2012
1Adrenal Cortex Hormones (Corticosteroids)IBA
12/2011
1Substance PIBA
10/2011
1Pharmaceutical PreparationsIBA
10/2009
1Collagen Type I (Type I Collagen)IBA
09/2009
1matrigelIBA
03/2009
1CardiotoxinsIBA
03/2009
1NucleotidesIBA
05/2008
1Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
12/2007
1Lysine (L-Lysine)FDA Link
09/2007
1Histidine (L-Histidine)FDA Link
09/2007
1Aspartic Acid (Aspartate)FDA Link
09/2007
1SaltsIBA
09/2007
1Hormones (Hormone)IBA
05/2007
1Explosive Agents (Explosives)IBA
09/2003
1Transcription Factors (Transcription Factor)IBA
09/2003
1chordinIBA
04/2003
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2003
1FollistatinIBA
04/2003
1NF-kappa B (NF-kB)IBA
01/2003

Therapy/Procedure

5Therapeutics
01/2022 - 05/2007
2Intramuscular Injections
12/2011 - 03/2009
1Enzyme Replacement Therapy
12/2014
1Transplantation
02/2007
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2007